Target intelligence / Profile preview

Ribosomal protein L37 pseudogene 25 (RPL37P25)

Target: RPL37P25
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L37 pseudogene 25 (RPL37P25) is a processed pseudogene in the human genome related to the functional ribosomal protein L37 gene (RPL37). Pseudogenes are gene sequences that closely resemble functional genes but are typically non-functional due to mutations or the absence of regulatory elements required for expression. There are many such pseudogenes for ribosomal proteins dispersed throughout the genome. RPL37P25 does not produce a functional protein product and is not considered a therapeutic or pharmacological target[1][3][6].

Other names: RPL37P25

Beyond the preview

Go deeper on Ribosomal protein L37 pseudogene 25 (RPL37P25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L37 pseudogene 25 (RPL37P25).

Explore the full profile